SEC Form 144 filed by Bridgewater Bancshares Inc.
144 - Bridgewater Bancshares Inc (0001341317) (Subject)
SEC Filings
Delayed 3mNon-insider SEC filings as they're submitted.
Signed out · 3-min delay · Sign up for real-time
- SEC Form SCHEDULE 13G filed by BRP Inc. Common Subordinate Voting Shares
SCHEDULE 13G - BRP Inc. (0001748797) (Subject)
- Amendment: SEC Form SCHEDULE 13G/A filed by Select Water Solutions Inc.
SCHEDULE 13G/A - Select Water Solutions, Inc. (0001693256) (Subject)
- Amendment: SEC Form SCHEDULE 13G/A filed by Ryerson Holding Corporation
SCHEDULE 13G/A - Ryerson Holding Corp (0001481582) (Subject)
- Amendment: SEC Form SCHEDULE 13G/A filed by Natural Gas Services Group Inc.
SCHEDULE 13G/A - NATURAL GAS SERVICES GROUP INC (0001084991) (Subject)
- SEC Form SCHEDULE 13G filed by Cantor Equity Partners VI Inc.
SCHEDULE 13G - Cantor Equity Partners VI, Inc. (0002089536) (Subject)
- SEC Form SCHEDULE 13G filed by Surf Air Mobility Inc.
SCHEDULE 13G - SURF AIR MOBILITY INC. (0001936224) (Subject)
- SEC Form SCHEDULE 13G filed by Sidus Space Inc.
SCHEDULE 13G - Sidus Space Inc. (0001879726) (Subject)
- SEC Form 144 filed by Vitesse Energy Inc.
144 - Vitesse Energy, Inc. (0001944558) (Subject)
- SEC Form 144 filed by Kinetik Holdings Inc.
144 - Kinetik Holdings Inc. (0001692787) (Subject)
- Lunai Bioworks Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Lunai Bioworks Inc. (0001527728) (Filer)
- Amendment: SEC Form SCHEDULE 13G/A filed by ALX Oncology Holdings Inc.
SCHEDULE 13G/A - ALX ONCOLOGY HOLDINGS INC (0001810182) (Subject)
- SEC Form S-1 filed by Rein Therapeutics Inc.
S-1 - Rein Therapeutics, Inc. (0001420565) (Filer)
- SEC Form 6-K filed by Waldencast plc
6-K - Waldencast plc (0001840199) (Filer)
- SEC Form 425 filed by Sun Country Airlines Holdings Inc.
425 - Sun Country Airlines Holdings, Inc. (0001743907) (Subject)
- SEC Form 6-K filed by EUDA Health Holdings Limited
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
- Amendment: SEC Form S-4/A filed by VYNE Therapeutics Inc.
S-4/A - VYNE Therapeutics Inc. (0001566044) (Filer)
- Ares Capital Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits
8-K - ARES CAPITAL CORP (0001287750) (Filer)